FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

36029711000001102: Octreotide 20mg powder and solvent for suspension for injection vials (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 28-Nov 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
111040601000001110 Octreotide 20mg powder and solvent for suspension for injection vials (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
111040701000001117 Octreotide 20mg powder and solvent for suspension for injection vials en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

2 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Octreotide 20mg powder and solvent for suspension for injection vials Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Intramuscular route true Inferred relationship Existential restriction modifier
Octreotide 20mg powder and solvent for suspension for injection vials Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route suspensioninjection.intramuscular-deep ontology form and route true Inferred relationship Existential restriction modifier
Octreotide 20mg powder and solvent for suspension for injection vials Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Octreotide 20mg powder and solvent for suspension for injection vials Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Octreotide 20mg powder and solvent for suspension for injection vials Is a Octreotide true Inferred relationship Existential restriction modifier
Octreotide 20mg powder and solvent for suspension for injection vials Is a Product containing octreotide false Inferred relationship Existential restriction modifier
Octreotide 20mg powder and solvent for suspension for injection vials Has active ingredient Octreotide false Inferred relationship Existential restriction modifier
Octreotide 20mg powder and solvent for suspension for injection vials Has dispensed dose form Powder and solvent for suspension for injection true Inferred relationship Existential restriction modifier
Octreotide 20mg powder and solvent for suspension for injection vials Has specific active ingredient Octreotide acetate true Inferred relationship Existential restriction modifier
Octreotide 20mg powder and solvent for suspension for injection vials VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Octreotide 20mg powder and solvent for suspension for injection vials VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Octreotide 20mg powder and solvent for suspension for injection vials Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Octreotide true Inferred relationship Existential restriction modifier
Octreotide 20mg powder and solvent for suspension for injection vials Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Olatuton 20mg powder and solvent for prolonged-release suspension for injection vials (Teva UK Ltd) Is a True Octreotide 20mg powder and solvent for suspension for injection vials Inferred relationship Existential restriction modifier
Octreotide 20mg powder and solvent for suspension for injection vials 1 vial Has VMP True Octreotide 20mg powder and solvent for suspension for injection vials Inferred relationship Existential restriction modifier
Sandostatin LAR 20mg powder and solvent for suspension for injection vials (Novartis Pharmaceuticals UK Ltd) Is a True Octreotide 20mg powder and solvent for suspension for injection vials Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start